Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Mepolizumab Chemical Structure
BCP13785 Mepolizumab 196078-29-2
Mepolizumab is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma.
Bimekizumab Chemical Structure
BCP30093 Bimekizumab 1418205-77-2
Bimekizumab is a monoclonal antibody that is being investigated for ankylosing spondylitis and psoriasis.
Romosozumab Chemical Structure
BCP29946 Romosozumab 909395-70-6
Romosozumab is a humanized monoclonal antibody against sclerostin, an inhibitor of osteoblastic activity.
Obinutuzumab Chemical Structure
BCP25211 Obinutuzumab 949142-50-1
Obinutuzumab (called afutuzumab until 2009,originally GA101) is a humanized anti-CD20 monoclonal antibody as a cancer treatment.
Secukinumab Chemical Structure
BCP26257 Secukinumab 875356-43-7
Secukinumab is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A.
Daratumumab Chemical Structure
BCP23828 Daratumumab 945721-28-8
Daratumumab is an IgG1k monoclonal antibody directed against CD38.
Blinatumomab Chemical Structure
BCP28744 Blinatumomab 853426-35-4
Blinatumomab specifically targets the CD19 antigen present on B cells.
Nimotuzumab Chemical Structure
BCP25910 Nimotuzumab 828933-51-3;780758-10-3
Nimotuzumab is a humanized monoclonal antibody and binds with optimal affinity and high specificity to the extracellular region of EGFR (epidermal growth factor receptor).
Adecatumumab Chemical Structure
BCP29455 Adecatumumab 503605-66-1
Adecatumumab is a recombinant human IgG1 monoclonal antibody which is used to target tumor cells.
Ipilimumab Chemical Structure
BCP25419 Ipilimumab 477202-00-9
Ipilimumab is a monoclonal antibody that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system.
123下一页末页共 39 条记录 1 / 4 页